AR047510A1 - Derivados de sulfonamida como agonistas de receptores adrenergicos ??2 - Google Patents
Derivados de sulfonamida como agonistas de receptores adrenergicos ??2Info
- Publication number
- AR047510A1 AR047510A1 ARP050100206A ARP050100206A AR047510A1 AR 047510 A1 AR047510 A1 AR 047510A1 AR P050100206 A ARP050100206 A AR P050100206A AR P050100206 A ARP050100206 A AR P050100206A AR 047510 A1 AR047510 A1 AR 047510A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- sulfonamide derivatives
- cycloalkyl
- formulas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/42—Y being a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La presente se refiere a derivados de sulfonamida como antagonistas de receptores adrenérgicos beta 2, procesos para su preparacion, composiciones farmacéuticas que los contienen y usos para trastornos y afecciones inflamatorios, alérgicos y respiratorios. Reivindicacion 1: Un compuesto de formula general (1) en la que el grupo (CH2)n-C(=O)Q1 está en posicion relativa meta o para, R1 y R2 se seleccionan independientemente de H y alquilo C1-4, n es 0, 1 o 2 y Q1 es un grupo que se selecciona entre las formulas (2) o (3) y un grupo *-NR11-Q2-A, en el que p es 1 o 2; Q2 es un alquileno C1-4 R11 es H o alquilo C1-4 y A es piridilo, cicloalquilo C3-10 siendo dicho cicloalquilo, opcionalmente esta puenteado por uno o más átomos de C, tetrahidropiranilo, piperidinilo opcionalmente sustituido con bencilo, tetrahidrotiopiranilo o un grupo de las formulas (4) o (5) en el que R3, R4, R5, R6 y R7 son iguales o diferentes y se seleccionan de H, alquilo C1-4, OR8, SR9, halo, CN, CF3, OCF3, COOR9, SO2NR9R10, CONR9R10, NR9R10, NHCOR10 y fenilo; en los que R8 es alquilo C1-4 y R9 y R10 son iguales o diferentes y se seleccionan de H o alquilo C1-4 y el * representa el punto de union al grupo carbonilo; o, si fuera apropiado, sus sales y/o isomeros, tautomeros, solvatos o variaciones isotopicas farmacéuticamente aceptables.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290168 | 2004-01-22 | ||
| GB0406388A GB0406388D0 (en) | 2004-03-22 | 2004-03-22 | Sulfonamide derivatives for the treatment of diseases |
| US60025904P | 2004-08-09 | 2004-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047510A1 true AR047510A1 (es) | 2006-01-25 |
Family
ID=43063961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100206A AR047510A1 (es) | 2004-01-22 | 2005-01-20 | Derivados de sulfonamida como agonistas de receptores adrenergicos ??2 |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US7351742B2 (es) |
| EP (1) | EP1708992B1 (es) |
| JP (1) | JP4036343B2 (es) |
| KR (1) | KR100785580B1 (es) |
| CN (1) | CN1910144B (es) |
| AP (1) | AP2378A (es) |
| AR (1) | AR047510A1 (es) |
| AT (1) | ATE369333T1 (es) |
| AU (1) | AU2005214154B2 (es) |
| BR (1) | BRPI0507041A (es) |
| CA (1) | CA2553293C (es) |
| CO (1) | CO5720993A2 (es) |
| CY (1) | CY1106894T1 (es) |
| DE (1) | DE602005001929T2 (es) |
| DK (1) | DK1708992T3 (es) |
| DO (1) | DOP2005000004A (es) |
| EA (1) | EA009735B1 (es) |
| EC (1) | ECSP066701A (es) |
| ES (1) | ES2289691T3 (es) |
| GE (1) | GEP20084452B (es) |
| HK (1) | HK1096083A1 (es) |
| HN (1) | HN2005000030A (es) |
| HR (1) | HRP20070452T3 (es) |
| IL (1) | IL176629A (es) |
| MA (1) | MA28303A1 (es) |
| ME (1) | ME00557A (es) |
| MY (1) | MY139690A (es) |
| NL (1) | NL1028086C2 (es) |
| NO (1) | NO20063761L (es) |
| NZ (1) | NZ548235A (es) |
| OA (1) | OA13361A (es) |
| PA (1) | PA8621901A1 (es) |
| PE (1) | PE20050765A1 (es) |
| PL (1) | PL1708992T3 (es) |
| PT (1) | PT1708992E (es) |
| RS (1) | RS50538B (es) |
| SI (1) | SI1708992T1 (es) |
| TW (1) | TWI273099B (es) |
| UA (1) | UA82283C2 (es) |
| UY (1) | UY28724A1 (es) |
| WO (1) | WO2005080324A1 (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| EP1907356A2 (en) * | 2005-07-18 | 2008-04-09 | Pfizer Limited | Process for the preparation of sulfonamide derivatives |
| WO2007017670A1 (en) | 2005-08-08 | 2007-02-15 | Argenta Discovery Ltd. | Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| EP1999107A2 (en) | 2006-03-20 | 2008-12-10 | Pfizer Limited | Amine derivatives |
| ATE549337T1 (de) | 2006-04-21 | 2012-03-15 | Novartis Ag | Purinderivate zur verwendung als adenosin-a2a- rezeptoragonisten |
| EP2074094A1 (en) * | 2006-10-04 | 2009-07-01 | Pfizer Limited | Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
| DE102007018151A1 (de) | 2007-04-16 | 2008-10-23 | Günenthal GmbH | Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln |
| US7713463B1 (en) * | 2007-11-13 | 2010-05-11 | Nuvasive, Inc. | Method of manufacturing embroidered surgical implants |
| PT2231642E (pt) | 2008-01-11 | 2014-03-12 | Novartis Ag | Pirimidinas como inibidores de quinase |
| US8263623B2 (en) * | 2008-07-11 | 2012-09-11 | Pfizer Inc. | Triazol derivatives useful for the treatment of diseases |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| EA019441B1 (ru) | 2008-12-30 | 2014-03-31 | Палмаджен Терепьютикс (Инфлеммейшн) Лимитед | Сульфонамиды, предназначенные для лечения респираторных нарушений |
| EP3210981B1 (en) | 2009-04-23 | 2019-01-02 | Theravance Respiratory Company, LLC | Diamide compounds having muscarinic receptor antagonist and beta 2 adrenergic receptor agonist activity |
| JP2012528140A (ja) | 2009-05-29 | 2012-11-12 | ファイザー・リミテッド | 新規なグルココルチコイド受容体アゴニスト |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
| CA2828219A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Pyrazolo [1,5-a] pyridines as trk inhibitors |
| ME02297B (me) | 2011-06-10 | 2016-02-20 | Chiesi Farm Spa | Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora |
| JP6421989B2 (ja) | 2012-12-06 | 2018-11-14 | チエシ ファルマスティスィ エス．ピー．エー． | ムスカリン受容体アンタゴニストおよびβ２アドレナリン受容体アゴニスト活性を有する化合物 |
| ES2663878T3 (es) | 2012-12-06 | 2018-04-17 | Chiesi Farmaceutici S.P.A. | Compuestos que tienen actividad antagonista del receptor muscarínico y actividad agonista del receptor beta-2 adrenérgico |
| WO2021260441A1 (en) | 2020-06-26 | 2021-12-30 | Mylan Pharma Uk Limited | Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4404224A (en) | 1981-12-02 | 1983-09-13 | American Cyanamid Company | Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals |
| US4540581A (en) * | 1984-01-31 | 1985-09-10 | Bristol-Myers Company | Topical nonsteroidal anti-inflammatory compositions and uses |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| JPH10218861A (ja) | 1997-02-04 | 1998-08-18 | Yamanouchi Pharmaceut Co Ltd | 新規なフェネタノール誘導体又はその塩 |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| US20020143034A1 (en) * | 1998-12-30 | 2002-10-03 | Fujisawa Pharmaceutical Co. Ltd. | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| OA11558A (en) | 1999-12-08 | 2004-06-03 | Advanced Medicine Inc | Beta 2-adrenergic receptor agonists. |
| AUPQ841300A0 (en) | 2000-06-27 | 2000-07-20 | Fujisawa Pharmaceutical Co., Ltd. | New aminoalcohol derivatives |
| US6465501B2 (en) | 2000-07-17 | 2002-10-15 | Wyeth | Azolidines as β3 adrenergic receptor agonists |
| US7048994B2 (en) * | 2001-02-23 | 2006-05-23 | Teijin Limited | Laminated polyester film and magnetic recording medium |
| US20030229058A1 (en) * | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
| JP2005527618A (ja) * | 2002-05-28 | 2005-09-15 | セラヴァンス インコーポレーテッド | アルコキシアリールβ２アドレナリン作動性レセプターアゴニスト |
| EP1477167A1 (en) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
-
2005
- 2005-01-12 GE GEAP20059537A patent/GEP20084452B/en unknown
- 2005-01-12 AP AP2006003671A patent/AP2378A/xx active
- 2005-01-12 RS RSP-2007/0409A patent/RS50538B/sr unknown
- 2005-01-12 AU AU2005214154A patent/AU2005214154B2/en not_active Ceased
- 2005-01-12 ME MEP-736/08A patent/ME00557A/xx unknown
- 2005-01-12 PL PL05702274T patent/PL1708992T3/pl unknown
- 2005-01-12 ES ES05702274T patent/ES2289691T3/es active Active
- 2005-01-12 CA CA2553293A patent/CA2553293C/en not_active Expired - Fee Related
- 2005-01-12 CN CN2005800030044A patent/CN1910144B/zh not_active Expired - Fee Related
- 2005-01-12 WO PCT/IB2005/000112 patent/WO2005080324A1/en active Application Filing
- 2005-01-12 JP JP2006550334A patent/JP4036343B2/ja not_active Expired - Fee Related
- 2005-01-12 DE DE602005001929T patent/DE602005001929T2/de active Active
- 2005-01-12 BR BRPI0507041-4A patent/BRPI0507041A/pt not_active IP Right Cessation
- 2005-01-12 EP EP05702274A patent/EP1708992B1/en active Active
- 2005-01-12 EA EA200601141A patent/EA009735B1/ru not_active IP Right Cessation
- 2005-01-12 DK DK05702274T patent/DK1708992T3/da active
- 2005-01-12 AT AT05702274T patent/ATE369333T1/de active
- 2005-01-12 SI SI200530059T patent/SI1708992T1/sl unknown
- 2005-01-12 NZ NZ548235A patent/NZ548235A/en not_active IP Right Cessation
- 2005-01-12 KR KR1020067014814A patent/KR100785580B1/ko not_active IP Right Cessation
- 2005-01-12 OA OA1200600233A patent/OA13361A/en unknown
- 2005-01-12 PT PT05702274T patent/PT1708992E/pt unknown
- 2005-01-18 TW TWSULFONAMIA patent/TWI273099B/zh not_active IP Right Cessation
- 2005-01-18 MY MYPI20050195A patent/MY139690A/en unknown
- 2005-01-19 US US11/038,416 patent/US7351742B2/en not_active Expired - Fee Related
- 2005-01-20 AR ARP050100206A patent/AR047510A1/es unknown
- 2005-01-20 PE PE2005000078A patent/PE20050765A1/es not_active Application Discontinuation
- 2005-01-20 DO DO2005000004A patent/DOP2005000004A/es unknown
- 2005-01-21 UY UY28724A patent/UY28724A1/es unknown
- 2005-01-21 PA PA20058621901A patent/PA8621901A1/es unknown
- 2005-01-21 NL NL1028086A patent/NL1028086C2/nl not_active IP Right Cessation
- 2005-01-21 HN HN2005000030A patent/HN2005000030A/es unknown
- 2005-12-01 UA UAA200608230A patent/UA82283C2/uk unknown
-
2006
- 2006-06-29 IL IL176629A patent/IL176629A/en not_active IP Right Cessation
- 2006-07-13 EC EC2006006701A patent/ECSP066701A/es unknown
- 2006-07-18 CO CO06070683A patent/CO5720993A2/es not_active Application Discontinuation
- 2006-07-21 MA MA29202A patent/MA28303A1/fr unknown
- 2006-08-22 NO NO20063761A patent/NO20063761L/no not_active Application Discontinuation
-
2007
- 2007-03-30 HK HK07103445.8A patent/HK1096083A1/xx not_active IP Right Cessation
- 2007-09-27 HR HR20070452T patent/HRP20070452T3/xx unknown
- 2007-09-27 CY CY20071101245T patent/CY1106894T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR047510A1 (es) | Derivados de sulfonamida como agonistas de receptores adrenergicos ??2 | |
| AR047509A1 (es) | Derivados de sulfonamida como antagonistas de receptores adrenergicos beta2 | |
| AR044475A1 (es) | Derivados de 2-amino -piridina utiles para el tratamiento de enfermedades | |
| AR044476A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
| AR048322A1 (es) | Compuestos para el tratamiento de afecciones inflamatorias, alergicas y respiratorias | |
| AR116993A2 (es) | Compuestos heterociclos bicíclicos y sus usos en terapia | |
| UY27322A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
| AR087760A1 (es) | Heterociclilaminas como inhibidores de pi3k | |
| AR044005A1 (es) | Compuestos biciclicos, procedimiento para su preparacion, su uso para preparar un medicamento y composiciones farmaceuticas que los comprenden | |
| AR069326A1 (es) | Derivados bis-(sulfonilamino), proceso de preparacion, composiciones farmaceuticas que los contienen y su uso en terapia. | |
| AR046394A1 (es) | Derivados de quinolinas y quinazolinas, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| AR065622A1 (es) | Derivados de 3-ciano -4- (4-fenil- piperidin -1- il) piridin -2- ona | |
| AR059184A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica | |
| AR052215A1 (es) | 3-aminociclopentancarboxamidas como moduladores de receptores de quimioquinas, su uso en el tratamiento de enfermedades relacionadas y composiciones farmacéuticas que las contienen. | |
| PE20050013A1 (es) | Composiciones farmaceuticas como inhibidores de la proteasa del virus de la hepatitis c | |
| CU23706B7 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| AR071856A1 (es) | Derivados de indazoles sustituidos con fenilo o piridinilo, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por el receptor de glucocorticoides. | |
| AR047098A1 (es) | Derivados de arilanilina como agonistas del receptor adrenergico beta2 | |
| AR066043A1 (es) | Derivados de benzamida sustituida como inhibidores de la 11-beta-hidroxi esteroide deshidrogenasa tipo 1(11betahsd1) | |
| AR107042A1 (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso | |
| AR048501A1 (es) | Compuesto de benzoazabicicloheptano dimerico, composicion farmaceutica que lo comprende y su uso para prepararla | |
| AR055171A1 (es) | Derivados de carboxamida como antagonistas del receptor muscarinico | |
| AR038404A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4, procedimiento para la preparacion del compuesto y composicion farmaceutica que lo incluye | |
| PE20200664A1 (es) | Compuestos espirociclicos y sus metodos de preparacion y uso | |
| AR092288A1 (es) | Ligandos del receptor ep1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |